A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to evaluate if Aripiprazole will prove to be
effective, safe and well tolerated in the treatment of patients with schizophrenia who are
treated in a general psychiatric setting.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.